Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Value of U.S. and European biotech initial public offerings (IPOs) in January-October 2017
(in million U.S. dollars)
Value of U.S. and EU biotech IPOs, January-October 2017
This statistic shows the value of select EU and U.S. biotech companies initial public offerings (IPOs) as reported between January and October 2017. According to the report, Biohaven Pharmaceutical Holding Company had a IPO valued at 193.5 million U.S. dollars.
Value of U.S. and European biotech initial public offerings (IPOs) in January-October 2017
(in million U.S. dollars)
Amount in million U.S. dollars
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

November 2017

Region

Europe, United States

Survey time period

January to October 2017

Value of U.S. and EU biotech IPOs, January-October 2017
This statistic shows the value of select EU and U.S. biotech companies initial public offerings (IPOs) as reported between January and October 2017. According to the report, Biohaven Pharmaceutical Holding Company had a IPO valued at 193.5 million U.S. dollars.
Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Statistics on "Biotech industry"
  • Global overview
  • U.S. companies
  • Research & development
  • Products
  • Funding/investment
  • Biotech in agriculture
Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.